Subscribe to
Alerts
Posts

Category Archive for 'Research'

Instead of a silver bullet to kill cancer cells, USC biologists discover a way to protect all other cells against chemotherapy; experts call the animal study a major advance in cancer research

Read Full Post »

Here we show that dexamethasone can reduce glioma growth in mice, even though it depletes infiltrating T cells with potential antitumor activity.

Read Full Post »

MRI scans could be used to determine which drug will work best against a brain tumor.

Read Full Post »

Melanie was 9 months old when her parents faced an agonizing decision. She had already had two operations for a malignant brain tumor, and doctors could not be sure they had removed all the cancer. She needed more treatment, but standard chemotherapy offered little hope in exchange for its harsh side effects. And yet the McDaniels knew that if they did nothing, the odds were high that the tumor would come back.

Read Full Post »

A discovery by St. Jude Children’s Research Hospital scientists suggests a safer way to treat medulloblastoma, a rare but often fatal childhood brain tumor.

Read Full Post »

Cotara® Appears Safe and Well Tolerated in Dosimetry and Phase II Trials, with Some Patients Already Past the Expected Median Average Survival Time for This Population – - Data From Dosimetry Trial Accepted for Presentation at 2008 ASCO Annual Meeting

Read Full Post »

A novel drug that fully eliminated brain tumors from mice in a dramatic 2004 study has shown a darker side—causing permanent bone damage in younger mice.

Read Full Post »

Scientists have developed a computer model that predicts the brain patterns elicited by looking at different images — a possible first step on the path to mind reading.

Read Full Post »

Scientists at a new cancer research facility will use a unique method to identify specific cells that grow brain tumours as they seek a cure for the deadly disease.

Read Full Post »

Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, today announced that Phase II data on the Company’s Neuradiab product candidate as a treatment for newly diagnosed glioblastoma multiforme (GBM) were published in the journal, Neuro-Oncology.

Read Full Post »

« Newer Posts - Older Posts »